Granza Bio

Granza Bio is a research-focused biotechnology company building on the discovery of autonomous cytotoxic "attack particles" released by cytotoxic immune cells. The company’s stated focus is to translate that discovery into approaches addressing cancer, autoimmunity, and infectious disease, based on research originating in an academic laboratory at the University of Oxford.